Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
article
TNO Identifier
882395
DOI
https://dx.doi.org/10.1111/liv.14643
Source
Liver International, 40(11), pp. 2860-2876.
Pages
2860-2876